Group 1 - The company, Zhongji Changshou Science, announced a joint venture agreement with Huali (Guangdong) Life Science Technology Co., Ltd. to establish a joint venture in China, with Zhongji Health holding 51% and Huali Life holding 49% of the equity [1] - The initial registered capital of the joint venture is set at RMB 1 million, which will be contributed by both parties according to their respective equity ratios [1] - The joint venture aims to provide longevity health services in China, capitalizing on the growing demand from affluent customers willing to invest in longevity science applications to enhance their overall health and immune status [1] Group 2 - The establishment of the joint venture aligns with the company's strategic development plan in the longevity science sector and is expected to benefit future business growth [2] - The joint venture will create a leading life science industry empowerment platform, integrating academic conferences, technology transfer, and industrial implementation into a cohesive ecosystem [2] - The board believes that the joint venture will enhance the company's positioning in the longevity science diagnostics and medical services field, opening new revenue sources for long-term stable and sustainable growth [2]
中基长寿科学(00767)拟与华骊生命成立合资公司，将主要从事于中国提供长寿健康服务